 | • レポートコード：GIR-107A14941 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、85ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、C-Cケモカイン受容体タイプ4のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。C-Cケモカイン受容体タイプ4の種類別市場規模（CCX-6239、E-0001163、GBV-3019、K-777、その他）、用途別市場規模（免疫、中枢神経系、菌状息肉腫、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・C-Cケモカイン受容体タイプ4の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Affitech A/S、AstraZeneca Plc、ChemoCentryx Inc、Corion Biotech Srl、FLX Bio Inc、Globavir Biosciences Inc、Kyowa Hakko Kirin Co Ltd、Ono Pharmaceutical Co Ltd ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：CCX-6239、E-0001163、GBV-3019、K-777、その他 ・用途別分析2016年-2026年：免疫、中枢神経系、菌状息肉腫、その他 ・C-Cケモカイン受容体タイプ4の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・C-Cケモカイン受容体タイプ4のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・C-Cケモカイン受容体タイプ4のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・C-Cケモカイン受容体タイプ4の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・C-Cケモカイン受容体タイプ4の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The C-C Chemokine Receptor Type 4 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global C-C Chemokine Receptor Type 4 size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global C-C Chemokine Receptor Type 4 market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
C-C Chemokine Receptor Type 4 market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
CCX-6239
E-0001163
GBV-3019
K-777
Others
Market segment by Application, can be divided into
Immunology
Central Nervous System
Mycosis Fungoides
Others
Market segment by players, this report covers
Affitech A/S
AstraZeneca Plc
ChemoCentryx Inc
Corion Biotech Srl
FLX Bio Inc
Globavir Biosciences Inc
Kyowa Hakko Kirin Co Ltd
Ono Pharmaceutical Co Ltd
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe C-C Chemokine Receptor Type 4 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of C-C Chemokine Receptor Type 4, with revenue, gross margin and global market share of C-C Chemokine Receptor Type 4 from 2019 to 2021.
Chapter 3, the C-C Chemokine Receptor Type 4 competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and C-C Chemokine Receptor Type 4 market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe C-C Chemokine Receptor Type 4 research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of C-C Chemokine Receptor Type 4
1.2 Classification of C-C Chemokine Receptor Type 4 by Type
1.2.1 Overview: Global C-C Chemokine Receptor Type 4 Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global C-C Chemokine Receptor Type 4 Revenue Market Share by Type in 2020
1.2.3 CCX-6239
1.2.4 E-0001163
1.2.5 GBV-3019
1.2.6 K-777
1.2.7 Others
1.3 Global C-C Chemokine Receptor Type 4 Market by Application
1.3.1 Overview: Global C-C Chemokine Receptor Type 4 Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Immunology
1.3.3 Central Nervous System
1.3.4 Mycosis Fungoides
1.3.5 Others
1.4 Global C-C Chemokine Receptor Type 4 Market Size & Forecast
1.5 Global C-C Chemokine Receptor Type 4 Market Size and Forecast by Region
1.5.1 Global C-C Chemokine Receptor Type 4 Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global C-C Chemokine Receptor Type 4 Market Size by Region, (2016-2021)
1.5.3 North America C-C Chemokine Receptor Type 4 Market Size and Prospect (2016-2026)
1.5.4 Europe C-C Chemokine Receptor Type 4 Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific C-C Chemokine Receptor Type 4 Market Size and Prospect (2016-2026)
1.5.6 South America C-C Chemokine Receptor Type 4 Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa C-C Chemokine Receptor Type 4 Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 C-C Chemokine Receptor Type 4 Market Drivers
1.6.2 C-C Chemokine Receptor Type 4 Market Restraints
1.6.3 C-C Chemokine Receptor Type 4 Trends Analysis
2 Company Profiles
2.1 Affitech A/S
2.1.1 Affitech A/S Details
2.1.2 Affitech A/S Major Business
2.1.3 Affitech A/S C-C Chemokine Receptor Type 4 Product and Solutions
2.1.4 Affitech A/S C-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Affitech A/S Recent Developments and Future Plans
2.2 AstraZeneca Plc
2.2.1 AstraZeneca Plc Details
2.2.2 AstraZeneca Plc Major Business
2.2.3 AstraZeneca Plc C-C Chemokine Receptor Type 4 Product and Solutions
2.2.4 AstraZeneca Plc C-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 AstraZeneca Plc Recent Developments and Future Plans
2.3 ChemoCentryx Inc
2.3.1 ChemoCentryx Inc Details
2.3.2 ChemoCentryx Inc Major Business
2.3.3 ChemoCentryx Inc C-C Chemokine Receptor Type 4 Product and Solutions
2.3.4 ChemoCentryx Inc C-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 ChemoCentryx Inc Recent Developments and Future Plans
2.4 Corion Biotech Srl
2.4.1 Corion Biotech Srl Details
2.4.2 Corion Biotech Srl Major Business
2.4.3 Corion Biotech Srl C-C Chemokine Receptor Type 4 Product and Solutions
2.4.4 Corion Biotech Srl C-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Corion Biotech Srl Recent Developments and Future Plans
2.5 FLX Bio Inc
2.5.1 FLX Bio Inc Details
2.5.2 FLX Bio Inc Major Business
2.5.3 FLX Bio Inc C-C Chemokine Receptor Type 4 Product and Solutions
2.5.4 FLX Bio Inc C-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 FLX Bio Inc Recent Developments and Future Plans
2.6 Globavir Biosciences Inc
2.6.1 Globavir Biosciences Inc Details
2.6.2 Globavir Biosciences Inc Major Business
2.6.3 Globavir Biosciences Inc C-C Chemokine Receptor Type 4 Product and Solutions
2.6.4 Globavir Biosciences Inc C-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Globavir Biosciences Inc Recent Developments and Future Plans
2.7 Kyowa Hakko Kirin Co Ltd
2.7.1 Kyowa Hakko Kirin Co Ltd Details
2.7.2 Kyowa Hakko Kirin Co Ltd Major Business
2.7.3 Kyowa Hakko Kirin Co Ltd C-C Chemokine Receptor Type 4 Product and Solutions
2.7.4 Kyowa Hakko Kirin Co Ltd C-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Kyowa Hakko Kirin Co Ltd Recent Developments and Future Plans
2.8 Ono Pharmaceutical Co Ltd
2.8.1 Ono Pharmaceutical Co Ltd Details
2.8.2 Ono Pharmaceutical Co Ltd Major Business
2.8.3 Ono Pharmaceutical Co Ltd C-C Chemokine Receptor Type 4 Product and Solutions
2.8.4 Ono Pharmaceutical Co Ltd C-C Chemokine Receptor Type 4 Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Ono Pharmaceutical Co Ltd Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global C-C Chemokine Receptor Type 4 Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 C-C Chemokine Receptor Type 4 Players Market Share
3.2.2 Top 10 C-C Chemokine Receptor Type 4 Players Market Share
3.2.3 Market Competition Trend
3.3 C-C Chemokine Receptor Type 4 Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global C-C Chemokine Receptor Type 4 Revenue and Market Share by Type (2016-2021)
4.2 Global C-C Chemokine Receptor Type 4 Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global C-C Chemokine Receptor Type 4 Revenue Market Share by Application (2016-2021)
5.2 C-C Chemokine Receptor Type 4 Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America C-C Chemokine Receptor Type 4 Revenue by Type (2016-2026)
6.2 North America C-C Chemokine Receptor Type 4 Revenue by Application (2016-2026)
6.3 North America C-C Chemokine Receptor Type 4 Market Size by Country
6.3.1 North America C-C Chemokine Receptor Type 4 Revenue by Country (2016-2026)
6.3.2 United States C-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)
6.3.3 Canada C-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)
6.3.4 Mexico C-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe C-C Chemokine Receptor Type 4 Revenue by Type (2016-2026)
7.2 Europe C-C Chemokine Receptor Type 4 Revenue by Application (2016-2026)
7.3 Europe C-C Chemokine Receptor Type 4 Market Size by Country
7.3.1 Europe C-C Chemokine Receptor Type 4 Revenue by Country (2016-2026)
7.3.2 Germany C-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)
7.3.3 France C-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)
7.3.4 United Kingdom C-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)
7.3.5 Russia C-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)
7.3.6 Italy C-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific C-C Chemokine Receptor Type 4 Revenue by Type (2016-2026)
8.2 Asia-Pacific C-C Chemokine Receptor Type 4 Revenue by Application (2016-2026)
8.3 Asia-Pacific C-C Chemokine Receptor Type 4 Market Size by Region
8.3.1 Asia-Pacific C-C Chemokine Receptor Type 4 Revenue by Region (2016-2026)
8.3.2 China C-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)
8.3.3 Japan C-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)
8.3.4 South Korea C-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)
8.3.5 India C-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia C-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)
8.3.7 Australia C-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America C-C Chemokine Receptor Type 4 Revenue by Type (2016-2026)
9.2 South America C-C Chemokine Receptor Type 4 Revenue by Application (2016-2026)
9.3 South America C-C Chemokine Receptor Type 4 Market Size by Country
9.3.1 South America C-C Chemokine Receptor Type 4 Revenue by Country (2016-2026)
9.3.2 Brazil C-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)
9.3.3 Argentina C-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa C-C Chemokine Receptor Type 4 Revenue by Type (2016-2026)
10.2 Middle East & Africa C-C Chemokine Receptor Type 4 Revenue by Application (2016-2026)
10.3 Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Country
10.3.1 Middle East & Africa C-C Chemokine Receptor Type 4 Revenue by Country (2016-2026)
10.3.2 Turkey C-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia C-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)
10.3.4 UAE C-C Chemokine Receptor Type 4 Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global C-C Chemokine Receptor Type 4 Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global C-C Chemokine Receptor Type 4 Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market C-C Chemokine Receptor Type 4 Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global C-C Chemokine Receptor Type 4 Revenue (USD Million) by Region (2016-2021)
Table 5. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Region (2021-2026)
Table 6. Affitech A/S Corporate Information, Head Office, and Major Competitors
Table 7. Affitech A/S Major Business
Table 8. Affitech A/S C-C Chemokine Receptor Type 4 Product and Solutions
Table 9. Affitech A/S C-C Chemokine Receptor Type 4 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. AstraZeneca Plc Corporate Information, Head Office, and Major Competitors
Table 11. AstraZeneca Plc Major Business
Table 12. AstraZeneca Plc C-C Chemokine Receptor Type 4 Product and Solutions
Table 13. AstraZeneca Plc C-C Chemokine Receptor Type 4 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. ChemoCentryx Inc Corporate Information, Head Office, and Major Competitors
Table 15. ChemoCentryx Inc Major Business
Table 16. ChemoCentryx Inc C-C Chemokine Receptor Type 4 Product and Solutions
Table 17. ChemoCentryx Inc C-C Chemokine Receptor Type 4 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Corion Biotech Srl Corporate Information, Head Office, and Major Competitors
Table 19. Corion Biotech Srl Major Business
Table 20. Corion Biotech Srl C-C Chemokine Receptor Type 4 Product and Solutions
Table 21. Corion Biotech Srl C-C Chemokine Receptor Type 4 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. FLX Bio Inc Corporate Information, Head Office, and Major Competitors
Table 23. FLX Bio Inc Major Business
Table 24. FLX Bio Inc C-C Chemokine Receptor Type 4 Product and Solutions
Table 25. FLX Bio Inc C-C Chemokine Receptor Type 4 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Globavir Biosciences Inc Corporate Information, Head Office, and Major Competitors
Table 27. Globavir Biosciences Inc Major Business
Table 28. Globavir Biosciences Inc C-C Chemokine Receptor Type 4 Product and Solutions
Table 29. Globavir Biosciences Inc C-C Chemokine Receptor Type 4 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Kyowa Hakko Kirin Co Ltd Corporate Information, Head Office, and Major Competitors
Table 31. Kyowa Hakko Kirin Co Ltd Major Business
Table 32. Kyowa Hakko Kirin Co Ltd C-C Chemokine Receptor Type 4 Product and Solutions
Table 33. Kyowa Hakko Kirin Co Ltd C-C Chemokine Receptor Type 4 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Ono Pharmaceutical Co Ltd Corporate Information, Head Office, and Major Competitors
Table 35. Ono Pharmaceutical Co Ltd Major Business
Table 36. Ono Pharmaceutical Co Ltd C-C Chemokine Receptor Type 4 Product and Solutions
Table 37. Ono Pharmaceutical Co Ltd C-C Chemokine Receptor Type 4 Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Global C-C Chemokine Receptor Type 4 Revenue (USD Million) by Players (2019-2021)
Table 39. Global C-C Chemokine Receptor Type 4 Revenue Share by Players (2019-2021)
Table 40. Breakdown of C-C Chemokine Receptor Type 4 by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. C-C Chemokine Receptor Type 4 Players Head Office, Products and Services Provided
Table 42. C-C Chemokine Receptor Type 4 Mergers & Acquisitions in the Past Five Years
Table 43. C-C Chemokine Receptor Type 4 New Entrants and Expansion Plans
Table 44. Global C-C Chemokine Receptor Type 4 Revenue (USD Million) by Type (2016-2021)
Table 45. Global C-C Chemokine Receptor Type 4 Revenue Share by Type (2016-2021)
Table 46. Global C-C Chemokine Receptor Type 4 Revenue Forecast by Type (2021-2026)
Table 47. Global C-C Chemokine Receptor Type 4 Revenue by Application (2016-2021)
Table 48. Global C-C Chemokine Receptor Type 4 Revenue Forecast by Application (2021-2026)
Table 49. North America C-C Chemokine Receptor Type 4 Revenue by Type (2016-2021) & (USD Million)
Table 50. North America C-C Chemokine Receptor Type 4 Revenue by Type (2021-2026) & (USD Million)
Table 51. North America C-C Chemokine Receptor Type 4 Revenue by Application (2016-2021) & (USD Million)
Table 52. North America C-C Chemokine Receptor Type 4 Revenue by Application (2021-2026) & (USD Million)
Table 53. North America C-C Chemokine Receptor Type 4 Revenue by Country (2016-2021) & (USD Million)
Table 54. North America C-C Chemokine Receptor Type 4 Revenue by Country (2021-2026) & (USD Million)
Table 55. Europe C-C Chemokine Receptor Type 4 Revenue by Type (2016-2021) & (USD Million)
Table 56. Europe C-C Chemokine Receptor Type 4 Revenue by Type (2021-2026) & (USD Million)
Table 57. Europe C-C Chemokine Receptor Type 4 Revenue by Application (2016-2021) & (USD Million)
Table 58. Europe C-C Chemokine Receptor Type 4 Revenue by Application (2021-2026) & (USD Million)
Table 59. Europe C-C Chemokine Receptor Type 4 Revenue by Country (2016-2021) & (USD Million)
Table 60. Europe C-C Chemokine Receptor Type 4 Revenue by Country (2021-2026) & (USD Million)
Table 61. Asia-Pacific C-C Chemokine Receptor Type 4 Revenue by Type (2016-2021) & (USD Million)
Table 62. Asia-Pacific C-C Chemokine Receptor Type 4 Revenue by Type (2021-2026) & (USD Million)
Table 63. Asia-Pacific C-C Chemokine Receptor Type 4 Revenue by Application (2016-2021) & (USD Million)
Table 64. Asia-Pacific C-C Chemokine Receptor Type 4 Revenue by Application (2021-2026) & (USD Million)
Table 65. Asia-Pacific C-C Chemokine Receptor Type 4 Revenue by Region (2016-2021) & (USD Million)
Table 66. Asia-Pacific C-C Chemokine Receptor Type 4 Revenue by Region (2021-2026) & (USD Million)
Table 67. South America C-C Chemokine Receptor Type 4 Revenue by Type (2016-2021) & (USD Million)
Table 68. South America C-C Chemokine Receptor Type 4 Revenue by Type (2021-2026) & (USD Million)
Table 69. South America C-C Chemokine Receptor Type 4 Revenue by Application (2016-2021) & (USD Million)
Table 70. South America C-C Chemokine Receptor Type 4 Revenue by Application (2021-2026) & (USD Million)
Table 71. South America C-C Chemokine Receptor Type 4 Revenue by Country (2016-2021) & (USD Million)
Table 72. South America C-C Chemokine Receptor Type 4 Revenue by Country (2021-2026) & (USD Million)
Table 73. Middle East & Africa C-C Chemokine Receptor Type 4 Revenue by Type (2016-2021) & (USD Million)
Table 74. Middle East & Africa C-C Chemokine Receptor Type 4 Revenue by Type (2021-2026) & (USD Million)
Table 75. Middle East & Africa C-C Chemokine Receptor Type 4 Revenue by Application (2016-2021) & (USD Million)
Table 76. Middle East & Africa C-C Chemokine Receptor Type 4 Revenue by Application (2021-2026) & (USD Million)
Table 77. Middle East & Africa C-C Chemokine Receptor Type 4 Revenue by Country (2016-2021) & (USD Million)
Table 78. Middle East & Africa C-C Chemokine Receptor Type 4 Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. C-C Chemokine Receptor Type 4 Picture
Figure 2. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Type in 2020
Figure 3. CCX-6239
Figure 4. E-0001163
Figure 5. GBV-3019
Figure 6. K-777
Figure 7. Others
Figure 8. C-C Chemokine Receptor Type 4 Revenue Market Share by Application in 2020
Figure 9. Immunology Picture
Figure 10. Central Nervous System Picture
Figure 11. Mycosis Fungoides Picture
Figure 12. Others Picture
Figure 13. Global C-C Chemokine Receptor Type 4 Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global C-C Chemokine Receptor Type 4 Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Region (2016-2026)
Figure 16. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Region in 2020
Figure 17. North America C-C Chemokine Receptor Type 4 Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe C-C Chemokine Receptor Type 4 Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific C-C Chemokine Receptor Type 4 Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America C-C Chemokine Receptor Type 4 Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Middle East and Africa C-C Chemokine Receptor Type 4 Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. C-C Chemokine Receptor Type 4 Market Drivers
Figure 23. C-C Chemokine Receptor Type 4 Market Restraints
Figure 24. C-C Chemokine Receptor Type 4 Market Trends
Figure 25. Affitech A/S Recent Developments and Future Plans
Figure 26. AstraZeneca Plc Recent Developments and Future Plans
Figure 27. ChemoCentryx Inc Recent Developments and Future Plans
Figure 28. Corion Biotech Srl Recent Developments and Future Plans
Figure 29. FLX Bio Inc Recent Developments and Future Plans
Figure 30. Globavir Biosciences Inc Recent Developments and Future Plans
Figure 31. Kyowa Hakko Kirin Co Ltd Recent Developments and Future Plans
Figure 32. Ono Pharmaceutical Co Ltd Recent Developments and Future Plans
Figure 33. Global C-C Chemokine Receptor Type 4 Revenue Share by Players in 2020
Figure 34. C-C Chemokine Receptor Type 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players C-C Chemokine Receptor Type 4 Revenue Market Share in 2020
Figure 36. Global Top 10 Players C-C Chemokine Receptor Type 4 Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global C-C Chemokine Receptor Type 4 Revenue Share by Type in 2020
Figure 39. Global C-C Chemokine Receptor Type 4 Market Share Forecast by Type (2021-2026)
Figure 40. Global C-C Chemokine Receptor Type 4 Revenue Share by Application in 2020
Figure 41. Global C-C Chemokine Receptor Type 4 Market Share Forecast by Application (2021-2026)
Figure 42. North America C-C Chemokine Receptor Type 4 Sales Market Share by Type (2016-2026)
Figure 43. North America C-C Chemokine Receptor Type 4 Sales Market Share by Application (2016-2026)
Figure 44. North America C-C Chemokine Receptor Type 4 Revenue Market Share by Country (2016-2026)
Figure 45. United States C-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada C-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico C-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe C-C Chemokine Receptor Type 4 Sales Market Share by Type (2016-2026)
Figure 49. Europe C-C Chemokine Receptor Type 4 Sales Market Share by Application (2016-2026)
Figure 50. Europe C-C Chemokine Receptor Type 4 Revenue Market Share by Country (2016-2026)
Figure 51. Germany C-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France C-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom C-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia C-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy C-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific C-C Chemokine Receptor Type 4 Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific C-C Chemokine Receptor Type 4 Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific C-C Chemokine Receptor Type 4 Revenue Market Share by Region (2016-2026)
Figure 59. China C-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan C-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea C-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India C-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia C-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia C-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America C-C Chemokine Receptor Type 4 Sales Market Share by Type (2016-2026)
Figure 66. South America C-C Chemokine Receptor Type 4 Sales Market Share by Application (2016-2026)
Figure 67. South America C-C Chemokine Receptor Type 4 Revenue Market Share by Country (2016-2026)
Figure 68. Brazil C-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina C-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa C-C Chemokine Receptor Type 4 Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa C-C Chemokine Receptor Type 4 Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa C-C Chemokine Receptor Type 4 Revenue Market Share by Country (2016-2026)
Figure 73. Turkey C-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia C-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE C-C Chemokine Receptor Type 4 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界のプロスタグランジンE2受容体EP2サブタイプ市場 2021：企業別、地域別、種類・用途別 The Prostaglandin E2 Receptor EP2 Subtype market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…- 世界のプロテイナーゼ活性化受容体2市場 2021：企業別、地域別、種類・用途別 The Proteinase Activated Receptor 2 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- 世界のトロンボポエチン受容体市場 2021：企業別、地域別、種類・用途別 The Thrombopoietin Receptor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 世界の副腎皮質刺激ホルモン受容体市場 2021：企業別、地域別、種類・用途別 The Adrenocorticotropic Hormone Receptor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 世界のメラニン凝集ホルモン受容体1市場 2021：企業別、地域別、種類・用途別 The Melanin Concentrating Hormone Receptor 1 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…